All News

RN.podcast.resized.jpg

RheumNow Podcast - Despite Corona (3.6.20)

d Jack Cush, MD

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.

Read Article
innovation.disrupt.high_.fly_.jpg

Need for Disruptive Innovation in Rheumatology

d Jack Cush, MD

A full-read, novel Viewpoint article published in the Annals of Rheumatic Disease (Huizinga TWJ, et al) spotlights a recent international meeting of big thinkers, scientific collaborators and industry dedicated to innovation in rheumatology.

Read Article
Scorpion.venom_.bug_.jpg

Venom Peptide-Steroid Conjugate Effective in Collagen Induced Arthritis

d Jack Cush, MD

Science Translational Medicine features a report from the Fred Hutchinson Cancer Research Center showing that a scopion venom peptide, coupled to steroid, can significantly reduce joint inflammation in a rat model of rheumatoid arthritis (RA).

Read Article
QD Clinic 85 - HOPE for Hand OA; Watch it here https://t.co/GNwt9ohHRe or listen to it on the podcaast https://t.co/xCwyYqx0sM

Links:

Dr. John Cush RheumNow ( View Tweet)

News » RheumNow Podcast is up (3.6.20)! Reports on GCA, ANA in Liver Dz, Sleep apnea in RA, COPD causing RA, Aldolase in Still's, Venon as a vector. Watch it here>> https://t.co/znNXBkziBD or listen to the podcast on iTunes or SoundCloud >> https://t.co/fVPAoXYPgW

Links:

Dr. John Cush RheumNow ( View Tweet)

Tocilizumab (Actemra) has been approved by the Chinese government to treat severe #coronavirus symptoms 👉🏽https://t.co/ETEQTga6GB #COVID2019 #COVID #CoronavirusOutbreak #Coronavid19 #covid19 #Covid_19 #CoronaAlert https://t.co/EoVGaYtkX4

Links:

Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
Check out the last 2 QD clinics on 7 DMARDs & counting and Kid Arthritis - on iTUNES or here >> https://t.co/4gDqvqHjnl and https://t.co/Lij5ot15gq

Links:

Dr. John Cush RheumNow ( View Tweet)

Breast cancer pts taking Aromatase Inhibitors have higher Risk of Arthritis (13% vs 8.2%, p < 0.0001) & carpal tunnel (1.4% vs 0.8%, p 0.008). Taiwanese Claims Analysis of 2,055 women w/ breast cancer taking tamoxifen, anastrozole, letrozole, exemestane. https://t.co/K7IzqjN28M

Links:

Dr. John Cush RheumNow ( View Tweet)

Fasting during Ramadan, 9th mo of Islamic calendar, with intermittent fasting (sunrise to sunset) shown to reduce Dz activity (compare pre/post fasting); 36 RA DAS 28 CRP decreased 4.3 to 3.5 (p < 0.001); 20 SpA pts 3.4  to 2.9 1.3 (p = 0.001). https://t.co/SI7jgXWz7w

Links:

Dr. John Cush RheumNow ( View Tweet)

Small phase II pilot trial of Tocilizumab in JIA (n=22) associated uveitis failed to show efficacy - 34% (7/21) responded to treatment (p=0·11). https://t.co/2EoCfLcVOA

Links:

Dr. John Cush RheumNow ( View Tweet)

"A fanatic is one who can't change his mind and won't change the subject" -Winston Churchill

Dr. John Cush RheumNow ( View Tweet)

Risk factors for severe cranial ischaemic complications (sCIC) in GCA studied in 295 pts - 61 developed sCIC. Vision complications increased with age & jaw claudication (OR 3.43); decreased with PMR Sxs & higher CRP. Afib independent predictor of stroke. https://t.co/8VoZoVGVIp

Links:

Dr. John Cush RheumNow ( View Tweet)

Study of 244 PsA &198 AS pts finds B27(+) in 25% PsA, 75% in AS. HLA‐B27 more likely to be younger, male, longer Dz duration, higher Xray scores. B27 was signif assoc w/ syndesmophyte symmetry, marginal syndesmophytes, but not sacroiliac symmetry. https://t.co/8MFVrTLWmF

Links:

Dr. John Cush RheumNow ( View Tweet)

ANA positivity very common with liver diseases - 91% in syst autoimmune dz, 93% in PBC, 49% Autoimmune hepatitis, 19% in HBV, 14% in HCV, 23.5% in Hepatocellular carcinoma; but few had ANA ≥ 1:320 (5 HCC, 2.5%HBV, 1.6% HCV). Patterns also varied. https://t.co/1wnr9sHjye

Links:

Dr. John Cush RheumNow ( View Tweet)

Apheresis not generally rec for SLE but .... Could be useful w alveolar hemorrhage, etc. Dr Compton #Utsw Rheum Grand Rounds https://t.co/fIBAMWVU4W
Dr. John Cush RheumNow ( View Tweet)

CAPS, best outcomes with triple therapy that includes Apheresis. Dr Compton #Utsw Rheum Grand Rounds https://t.co/MVesTmSNQK

Dr. John Cush RheumNow ( View Tweet)

Criteria for CAPS. Dr. Compton #Utsw Rheum Grand Rounds https://t.co/tdVWhMEII3

Dr. John Cush RheumNow ( View Tweet)
Indications for Apheresis Dr Compton #Utsw Rheum Grand Rounds @FrancesComptonx https://t.co/CLfSMgdQkL
Dr. John Cush RheumNow ( View Tweet)
With 5 plans exchanges you can reduce IgG by 85 % Dr Compton #Utsw Rheum Grand Rounds https://t.co/zsxn07Z8r6
Dr. John Cush RheumNow ( View Tweet)
Dr. Frances Compton #Utsw Rheum Grand Rounds on Therapeutic Apheresis - able to remove https://t.co/6V5i8bwXY3
Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×